Medical oncologists' perception of antiestrogen therapy benefit in premenopausal women with hormone receptor-positive early-stage breast cancer

Ann Oncol. 2018 Mar 1;29(3):772-773. doi: 10.1093/annonc/mdx719.

Authors

R Patel¹, S Maxwell¹, D Yan², E V Dressler³, E H Romond¹, A Mathew⁴

Affiliations

¹ Division of Medical Oncology, Markey Cancer Center, University of Kentucky, Lexington.
² Division of Cancer Biostatistics, College of Public Health, University of Kentucky, Lexington.
³ Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, USA.
⁴ Division of Medical Oncology, Markey Cancer Center, University of Kentucky, Lexington; Kerala Cancer Care, Kochi, Kerala, India. Electronic address: aju.mathew@uky.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Breast Neoplasms / drug therapy*
Cross-Sectional Studies
Estrogen Receptor Modulators / therapeutic use*
Female
Health Knowledge, Attitudes, Practice*
Humans
Medical Oncology*
Oncologists
Premenopause
Surveys and Questionnaires

Substances

Estrogen Receptor Modulators

Grants and funding

P30 CA177558/CA/NCI NIH HHS/United States